期刊
CARDIOLOGY
卷 130, 期 4, 页码 211-220出版社
KARGER
DOI: 10.1159/000369782
关键词
Left ventricular hypertrophy; 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography Glucose 6-phosphate; Mechanistic target of rapamycin activation; Endoplasmic reticulum stress
资金
- US Public Health Service [HL R21-102627, HL R01-61483]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL102627, R01HL061483] Funding Source: NIH RePORTER
When subjected to pressure overload, the ventricular myocardium shifts from fatty acids to glucose as its main source for energy provision and frequently increases its mass. Here, we review the evidence in support of the concept that metabolic remodeling, measured as an increased myocardial glucose uptake using dynamic positron emission tomography (PET) with the glucose analogue 2-deoxy-2-[F-18]fluoro- D-glucose (FDG), precedes the onset of left ventricular hypertrophy (LVH) and heart failure. Consistent with this, early intervention with propranolol, which attenuates glucose uptake, prevents the maladaptive metabolic response and preserves cardiac function in vivo. We also review ex vivo studies suggesting a link between dysregulated myocardial glucose metabolism, intracellular accumulation of glucose 6-phosphate (G6P) and contractile dysfunction of the heart. G6P levels correlate with activation of mTOR (mechanistic target of rapamycin) and endoplasmic reticulum stress. This sequence of events could be prevented by pretreatment with rapamycin (mTOR inhibition) or metformin (enzyme 5'-AMP-activated protein kinase activation). In conclusion, we propose that metabolic imaging with FDG PET may provide a novel approach to guide the treatment of patients with hypertension-induced LVH. (C) 2015 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据